Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
5,970.00
+90.00 (1.53%)
At close: Sep 18, 2025
Jin Yang Pharmaceutical Revenue
Jin Yang Pharmaceutical had revenue of 30.18B KRW in the quarter ending June 30, 2025, with 9.83% growth. This brings the company's revenue in the last twelve months to 119.56B, up 15.85% year-over-year. In the year 2024, Jin Yang Pharmaceutical had annual revenue of 113.33B with 20.94% growth.
Revenue (ttm)
119.56B
Revenue Growth
+15.85%
P/S Ratio
0.60
Revenue / Employee
543.44M
Employees
220
Market Cap
71.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 113.33B | 19.62B | 20.94% |
Dec 31, 2023 | 93.71B | 17.44B | 22.87% |
Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
Dec 31, 2020 | 49.52B | 2.17B | 4.59% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |